Remove Biotechnology Remove Development Remove Software
article thumbnail

Regeneron and auticon open doors for autistic IT professionals

CIO Business Intelligence

Thats why auticon started the Auticon Training Institute (ATI), a US nonprofit offering structured IT and tech training pathways, certifications, internships, mentorships, and networking opportunities free of charge for autistic adults, empowering them to start careers in software engineering, data analysis, cybersecurity, and more.

Training 264
article thumbnail

Cyrus Biotech spins out company to expand reach of versatile drug development software

GeekWire

Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. The foundation was created by RosettaCommons, a multi-institution coalition that built a software platform called Rosetta that is used for modeling biomolecular compounds.

Software 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more

GeekWire

Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. Rubinstein joined Adaptive in 2011 as senior vice president of corporate and business development and became president seven years later. Mark Adams.

article thumbnail

The 10 highest-paying industries for IT talent

CIO Business Intelligence

Every business unit has a stake in the IT services, apps, networks, hardware, and software needed to meet business goals and objectives, and many of them are hiring their own technologists. Healthcare Technology is paramount for the healthcare industry, including the medical, pharmaceutical, and biotechnology industries.

Industry 306
article thumbnail

Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation

GeekWire

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo). It values the company at $900 million.

article thumbnail

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

GeekWire

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

article thumbnail

GREEN500 Supercomputer Powering Robot Scientists and Transformational Machine Learning

CIO Business Intelligence

Using HPC from the University of Cambridge, researchers are creating a new method of machine learning whereby the computer ‘learns how to learn’—which could advance studies in drug development and disease treatment. A team from the UK, Sweden, India, and the Netherlands developed the approach, known as transformational machine learning (TML).

Dell 355